Thrombolysis: Improving door-to-needle times for ischemic stroke treatment - A narrative review
- PMID: 29140185
- DOI: 10.1177/1747493017743060
Thrombolysis: Improving door-to-needle times for ischemic stroke treatment - A narrative review
Abstract
Background The effectiveness of thrombolysis is highly time dependent. For this reason, short target times have been set to reduce time to treatment from hospital arrival, which is called door-to-needle time. Summary of review There has been considerable work done at single centers and across multiple hospitals to improve door-to-needle time. There have been reductions of 8 to 47 min when applying one or more improvement strategies at single centers, and there have been many multi-hospital initiatives. The delays to treatment have been attributed to both patient and hospital factors, and strategies to address these delays have been proven to reduce door-to-needle time. The most effective strategies include pre-notification of arrival by Emergency Medical Services (EMS), single-call activation of stroke team, rapid registration process, moving the patient to computed tomography on EMS stretcher, and administration of alteplase in the scanner. There are many exciting areas of future direction including reduction of door-to-needle time in developing countries, improving pre-hospital response times, and improving the efficiency of endovascular treatment. Conclusions There is now a broad understanding of the causes of delays to fast treatment and the strategies that can be employed to improve door-to-needle time such that most centers could achieve median door-to-needle time of 30 min.
Keywords: Acute stroke; door-to-needle; thrombolysis.
Similar articles
-
Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):e003242. doi: 10.1161/CIRCOUTCOMES.116.003242. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28096208
-
Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke.Int J Stroke. 2011 Dec;6(6):493-7. doi: 10.1111/j.1747-4949.2011.00585.x. Epub 2011 Feb 17. Int J Stroke. 2011. PMID: 21609415
-
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210. Epub 2012 Jul 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22787065
-
Minimising time to treatment: targeted strategies to minimise time to thrombolysis for acute ischaemic stroke.Intern Med J. 2013 Nov;43(11):1176-82. doi: 10.1111/imj.12204. Intern Med J. 2013. PMID: 23734983 Review.
-
Meta-analysis of interventions to reduce door to needle times in acute ischaemic stroke patients.BMJ Open Qual. 2020 Aug;9(3):e000915. doi: 10.1136/bmjoq-2020-000915. BMJ Open Qual. 2020. PMID: 32747390 Free PMC article.
Cited by
-
Quality improvement project to improve patient outcomes by reducing door to CT and door to needle time and increasing appropriate referrals for endovascular thrombectomy.BMJ Open Qual. 2022 Jan;11(1):e001429. doi: 10.1136/bmjoq-2021-001429. BMJ Open Qual. 2022. PMID: 35017174 Free PMC article.
-
Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.BMJ Open. 2019 Dec 15;9(12):e032482. doi: 10.1136/bmjopen-2019-032482. BMJ Open. 2019. PMID: 31843839 Free PMC article. Clinical Trial.
-
Impact of implementing a stroke code on the door to needle time during Hajj at a tertiary center in Makkah, Saudi Arabia.Neurosciences (Riyadh). 2023 Jul;28(3):190-194. doi: 10.17712/nsj.2023.3.20220141. Neurosciences (Riyadh). 2023. PMID: 37482386 Free PMC article.
-
Improving stroke care in Nova Scotia, Canada: a population-based project spanning 14 years.BMJ Open Qual. 2021 Sep;10(3):e001368. doi: 10.1136/bmjoq-2021-001368. BMJ Open Qual. 2021. PMID: 34561278 Free PMC article.
-
Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.Neurol Med Chir (Tokyo). 2019 Dec 15;59(12):449-491. doi: 10.2176/nmc.st.2019-0177. Epub 2019 Dec 5. Neurol Med Chir (Tokyo). 2019. PMID: 31801934 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous